Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain, Postoperative 2 Pain 2 Ovarian Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Renal Cell 2 Agnosia 2 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Lymphoma 1 Kidney Neoplasms 1 Ileus 1 Head and Neck Neoplasms 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Curative Breast Cancer Surgery 1 Constipation 1 Colonic Neoplasms 1 Chronic Pain 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Female 1 Acute Pain 1

Interventions

Sunitinib 26 Everolimus 20 Bevacizumab 19 aldesleukin 18 Sorafenib 16 Nivolumab 16 Interleukin-2 14 pembrolizumab 13 Peripheral Blood Stem Cell Transplantation 13 fludarabine phosphate 12 Radiotherapy 12 Interferon-alpha 12 Cyclophosphamide 12 Radiosurgery 11 Filgrastim 11 Blood Specimen Collection 11 Ipilimumab 10 Gemcitabine 10 Axitinib 9 Surveys and Questionnaires 7 Gene Expression Profiling 7 Cryosurgery 7 temsirolimus 6 pazopanib 6 Surgical Procedures, Operative 6 durvalumab 5 cabozantinib 5 atezolizumab 5 Mycophenolic Acid 5 Immunohistochemistry 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Kidney Neoplasms × Ketorolac Tromethamine × Clear all

NCT05842044 2025-09-05

No-PAIN

University of Miami

Phase 2 Recruiting

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡